Novel Prognostic Markers in Renal Cancer

Royal Marsden NHS Foundation Trust

Status: Completed

Conditions: Renal Cell Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT01002937

CCR3076

Details and patient eligibility

About

The purpose of this project is to analyze tumour tissue from a group of subjects with renal cell carcinoma, who have been treated at the Royal Marsden Hospital.

Full description

Renal cancers have different clinical outcomes. The principal research objective is to study tumour tissue from renal cancer patients and try and understand why some cancers progress more rapidly than others. Further, another key aim of this study is to try and understand why some patients respond to treatment and others do not.

Enrollment: 182 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The presence of histologically proven renal cell cancer
• The availability of paraffin embedded tissue
• Informed consent needed for tissue taken after January 2006 (date of enforcement of human tissue act)

Exclusion criteria

• Absence of histological tissue
• Absence of consent to study tissue after January 2006

Trial design

182 participants in 1 patient group

Tumour tissue, renal cell carcinoma

Description:

\> 2mm x 2mm of tumour tissue obtained from paraffin blocks taken from biopsies or nephrectomy specimens.